Chief Medical Officer & Head of Pharmacovigilance
Pharmacovigilance
Obseva
Switzerland
Elke Bestel joined ObsEva in September 2015 as the Chief Medical Officer & Head of Pharmacovigilance, bringing with her about 19 years of experience in pharmaceutical product development. Prior to joining ObsEva, Elke was the CMO at PregLem, a Swiss based specialty biopharmaceutical company. She was one of the key players in the successful development and European registration of Esmya®. Prior to PregLem, she worked for Galderma, France, where she was responsible for clinical studies as well as development, registration and life-cycle activities of dermatological products (Epiduo®, Soolantra®, Adapalene® and Clindagel®). Before joining Galderma, she worked at the clinical research organization MDS, France where she was responsible for conduct of the clinical studies from Phase I to III. Elke holds a MD degree from the University of Göttingen, Germany, and received training in gynecology at the Kantonsspital Bruderholz, Switzerland.
pharmaceutical product development. gynecology